87 related articles for article (PubMed ID: 28706123)
1. Cerebral Microbleeds in Murine Amyloid Angiopathy: Natural Course and Anticoagulant Effects.
Marinescu M; Sun L; Fatar M; Neubauer A; Schad L; van Ryn J; Lehmann L; Veltkamp R
Stroke; 2017 Aug; 48(8):2248-2254. PubMed ID: 28706123
[TBL] [Abstract][Full Text] [Related]
2. Cerebral Microbleed Patterns and Cortical Amyloid-β: The ARIC-PET Study.
Okine DN; Knopman DS; Mosley TH; Wong DF; Johansen MC; Walker KA; Jack CR; Kantarci K; Pike JR; Graff-Radford J; Gottesman RF
Stroke; 2023 Oct; 54(10):2613-2620. PubMed ID: 37638398
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular Management in Asymptomatic (Silent) Cerebral Microbleeds and Suspected Cerebral Amyloid Angiopathy.
Charidimou A; Smith EE
Stroke; 2024 Apr; 55(4):1101-1112. PubMed ID: 38465605
[TBL] [Abstract][Full Text] [Related]
4. Cerebral microbleeds: Prevalence and relationship to amyloid burden.
Graff-Radford J; Botha H; Rabinstein AA; Gunter JL; Przybelski SA; Lesnick T; Huston J; Flemming KD; Preboske GM; Senjem ML; Brown RD; Mielke MM; Roberts RO; Lowe VJ; Knopman DS; Petersen RC; Kremers W; Vemuri P; Jack CR; Kantarci K
Neurology; 2019 Jan; 92(3):e253-e262. PubMed ID: 30568001
[TBL] [Abstract][Full Text] [Related]
5. Cerebral Microbleeds, Vascular Risk Factors, and Magnetic Resonance Imaging Markers: The Northern Manhattan Study.
Caunca MR; Del Brutto V; Gardener H; Shah N; Dequatre-Ponchelle N; Cheung YK; Elkind MS; Brown TR; Cordonnier C; Sacco RL; Wright CB
J Am Heart Assoc; 2016 Sep; 5(9):. PubMed ID: 27638784
[TBL] [Abstract][Full Text] [Related]
6. Cerebral Microbleeds in Advanced Dementia: Clinical and Pathological Correlates.
Boyano I; Ramos A; López-Alvarez J; Mendoza-Rebolledo C; Osa-Ruiz E; Rodríguez I; Pérez A; Alfayate E; González B; Fernández L; Agüera-Ortiz L; Rábano A; Olazarán J
Am J Alzheimers Dis Other Demen; 2018 Sep; 33(6):362-372. PubMed ID: 29734821
[TBL] [Abstract][Full Text] [Related]
7. Cerebral microhemorrhages due to traumatic brain injury and their effects on the aging human brain.
Irimia A; Van Horn JD; Vespa PM
Neurobiol Aging; 2018 Jun; 66():158-164. PubMed ID: 29579686
[TBL] [Abstract][Full Text] [Related]
8. Neuropathologic correlates of cerebral microbleeds in community-based older adults.
Nikseresht G; Evia AM; Nag S; Leurgans SE; Capuano AW; Agam G; Barnes LL; Bennett DA; Schneider JA; Arfanakis K
Neurobiol Aging; 2023 Sep; 129():89-98. PubMed ID: 37279617
[TBL] [Abstract][Full Text] [Related]
9. Secondary Bleeding During Acute Experimental Intracerebral Hemorrhage.
Schlunk F; Böhm M; Boulouis G; Qin T; Arbel M; Tamim I; Fischer P; Bacskai BJ; Frosch MP; Endres M; Greenberg SM; Ayata C
Stroke; 2019 May; 50(5):1210-1215. PubMed ID: 31009358
[TBL] [Abstract][Full Text] [Related]
10. Loss of spontaneous vasomotion precedes impaired cerebrovascular reactivity and microbleeds in a mouse model of cerebral amyloid angiopathy.
Kozberg MG; Munting LP; Maresco LH; Auger CA; van den Berg ML; Denis de Senneville B; Hirschler L; Warnking JM; Barbier EL; Farrar CT; Greenberg SM; Bacskai BJ; van Veluw SJ
bioRxiv; 2024 Apr; ():. PubMed ID: 38746419
[TBL] [Abstract][Full Text] [Related]
11. Dilated Juxtacortical Perivascular Spaces and Venous Cerebral Microbleeds in Cerebral Amyloid Angiopathy-Related Inflammation.
Wang Y; Fan X; Ni J; Feng F
Ann Neurol; 2023 Sep; 94(3):605-607. PubMed ID: 37367251
[No Abstract] [Full Text] [Related]
12. Anticoagulation in patients with cerebral amyloid angiopathy.
Shoamanesh A;
Lancet; 2023 Oct; 402(10411):1418-1419. PubMed ID: 37839419
[No Abstract] [Full Text] [Related]
13. Therapeutic modulation of cerebral microhemorrhage in a mouse model of cerebral amyloid angiopathy.
Fisher M; Vasilevko V; Passos GF; Ventura C; Quiring D; Cribbs DH
Stroke; 2011 Nov; 42(11):3300-3. PubMed ID: 21903962
[TBL] [Abstract][Full Text] [Related]
14. Triple therapy with dual antiplatelet treatment and direct oral anticoagulants.
Sorigue M; Sarrate E; Delcastillo J
Eur J Intern Med; 2018 Jan; 47():e20. PubMed ID: 28709709
[No Abstract] [Full Text] [Related]
15. Recent advances in the treatment of venous thromboembolism in the era of the direct oral anticoagulants.
Weitz JI; Jaffer IH; Fredenburgh JC
F1000Res; 2017; 6():985. PubMed ID: 28713563
[TBL] [Abstract][Full Text] [Related]
16. Brain hemorrhage recurrence, small vessel disease type, and cerebral microbleeds: A meta-analysis.
Charidimou A; Imaizumi T; Moulin S; Biffi A; Samarasekera N; Yakushiji Y; Peeters A; Vandermeeren Y; Laloux P; Baron JC; Hernandez-Guillamon M; Montaner J; Casolla B; Gregoire SM; Kang DW; Kim JS; Naka H; Smith EE; Viswanathan A; Jäger HR; Al-Shahi Salman R; Greenberg SM; Cordonnier C; Werring DJ
Neurology; 2017 Aug; 89(8):820-829. PubMed ID: 28747441
[TBL] [Abstract][Full Text] [Related]
17. Effects of Non-Vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation and Valvular Heart Disease: A Systematic Review and Meta-Analysis.
Pan KL; Singer DE; Ovbiagele B; Wu YL; Ahmed MA; Lee M
J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28720644
[TBL] [Abstract][Full Text] [Related]
18. Real-World Setting Comparison of Nonvitamin-K Antagonist Oral Anticoagulants Versus Vitamin-K Antagonists for Stroke Prevention in Atrial Fibrillation: A Systematic Review and Meta-Analysis.
Ntaios G; Papavasileiou V; Makaritsis K; Vemmos K; Michel P; Lip GYH
Stroke; 2017 Sep; 48(9):2494-2503. PubMed ID: 28716982
[TBL] [Abstract][Full Text] [Related]
19. Platelet Aggregation in Direct Oral Factor Xa Inhibitors-treated Patients With Atrial Fibrillation: A Pilot Study.
Bánovčin P; Škorňová I; Samoš M; Schnierer M; Bolek T; Kovář F; Staško J; Kubisz P; Mokáň M
J Cardiovasc Pharmacol; 2017 Oct; 70(4):263-266. PubMed ID: 28708713
[TBL] [Abstract][Full Text] [Related]
20. Non-Vitamin K Oral Anticoagulants (NOACs) and Their Reversal.
Reddy ST; Cossey TC; Savitz SI; Grotta JC
Curr Neurol Neurosci Rep; 2017 Sep; 17(9):67. PubMed ID: 28735353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]